Rice’s SynthX Center leads interdisciplinary effort to tackle rare lymphatic disorders +++

Rice’s SynthX Center leads interdisciplinary effort to tackle rare lymphatic disorders https://www.news-medical.net/news/20260120/Ricee28099s-SynthX-Center-leads-interdisciplinary-effort-to-tackle-rare-lymphatic-disorders.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_27_january_2026 Rice University's SynthX Center, directed by Han Xiao, has received an up to five-year, $18 million award from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics and pHenotyping Technologies (LIGHT) program to develop innovative solutions for lymphatic diseases. New pangenomic approach enables unprecedented scaling for genetic data https://www.azolifesciences.com/news/20260114/New-Pangenomic-Approach-Enables-Unprecedented-Scaling-for-Genetic-Data.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_27_january_2026 Researchers at the University of California have created a novel data structure and compression method that allows pangenomics to process genetic information at previously unattainable scales. FIU's personalized cancer treatment shows promise https://www.news-medical.net/news/20260122/FIUs-personalized-cancer-treatment-shows-promise.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_27_january_2026 Researchers at FIU are advancing a personalized approach to cancer treatment that is showing increasingly promising results for patients with hard-to-treat disease, supported by new philanthropic investment that is helping expand the science behind the work.